38240-26-5

Usage

Uses

Used in Pharmaceutical and Agrochemical Synthesis:
4-(Methylthio)pyridin-2-aMine is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals, leveraging its unique chemical structure to contribute to the development of new and effective compounds.
Used in Dye and Pigment Production:
MPI is employed as a building block in the production of dyes and pigments, where its chemical properties are harnessed to create a range of colorants for different applications.
Used in Specialty Chemicals Development:
4-(Methylthio)pyridin-2-aMine is used as a component in the development of specialty chemicals, where its specific characteristics are applied to enhance the performance of these chemicals in various industries.
Used in Medicinal Chemistry Research:
MPI is studied for its potential biological activities, such as antioxidant and anti-inflammatory properties, making it a valuable subject in the research and development of new therapeutic agents.

Upstream product

• 19798-80-2 2-Amino-4-chloropyridine 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 1192251-96-9 2-(4-bromophenyl)-7-(methylthio)imidazo[1,2-a]pyridine 
• 1192251-80-1 2-(3'-fluorobiphenyl-4-yl)-7-(methylsulfonyl)imidazo[1,2-a]pyridine 
• 1609531-08-9 C₂₀H₂₀FN₅O₂S 

Relevant academic research and scientific papers

P2X3 MODULATORS

Provided herein are P2X3 modulators and methods of utilizing P2X3 modulators in the treatment of diseases, disorders, or conditions. Also described herein are pharmaceutical compositions containing such compounds.

HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE

The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula (I): wherein the variables of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a metabolic or cardiovascular disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Substituted heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; Type 2 diabetes; insulin resistance; hyperglycemia; Metabolic Syndrome; neurological disease; cancer; and liver steatosis. Formula (I).

Substituted 2-aminopyridines as inhibitors of nitric oxide synthase

Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. STR1